Cargando…
Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status
There are few treatment guidelines for locally recurrent esophageal cancer after trimodality treatment (pre-operative chemoradiation followed by surgery) in patients with a poor performance status. The purpose of this single institutional, retrospective study was to evaluate the clinical outcomes an...
Autores principales: | W. Kim, Daniel, Raoof, Sana, Lamba, Nayan, Lee, Grace, S. Bitterman, Danielle, R. Mahal, Amandeep, N. Sanford, Nina, B. Lam, Miranda, J. Mamon, Harvey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241232/ https://www.ncbi.nlm.nih.gov/pubmed/32454972 http://dx.doi.org/10.3892/mco.2020.2044 |
Ejemplares similares
-
Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer
por: Gaber, Charles E, et al.
Publicado: (2022) -
Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012) -
Assessment of a collaborative treatment model for trimodal management of esophageal cancer
por: Udelsman, Brooks V., et al.
Publicado: (2023) -
Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
por: Xu, Xiujuan, et al.
Publicado: (2019) -
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)